GNH USA

Europe — EMA

Glucosio E Sodio Cloruro I Galenica Senese

Glucosio E Sodio Cloruro I Galenica Senese is an EU‑manufactured sterile IV solution of sodium chloride and glucose for fluid, electrolyte and energy replacement.

Sodium Chloride, Glucose Monohydrate

Request sourcing

1
Pack/s

What is Sodium Chloride, Glucose Monohydrate?

Glucosio E Sodio Cloruro I Galenica Senese is a sterile injectable solution containing sodium chloride and glucose monohydrate. It is supplied in a standard concentration suitable for intravenous administration. The product is manufactured in the European Union and is classified as a prescription‑only electrolyte and carbohydrate solution used for fluid and energy support. It is packaged in a sterile vial for single‑use infusion and hospital clinical use.

What is Sodium Chloride, Glucose Monohydrate used for?

Glucosio E Sodio Cloruro I Galenica Senese is indicated for several clinical situations where intravenous fluid and energy replacement are required.

- Fluid and electrolyte replacement in patients with dehydration or loss due to surgery, trauma, or gastrointestinal losses. - Treatment of hypoglycemia when oral glucose administration is not feasible. - Component of parenteral nutrition regimens to provide carbohydrate calories. - Maintenance of extracellular fluid volume during peri‑operative care. - Support for patients receiving blood transfusions or massive fluid resuscitation.

What are the side effects of Sodium Chloride, Glucose Monohydrate?

Adverse reactions to Glucosio E Sodio Cloruro I Galenica Senese are generally infrequent, but they may occur with any intravenous solution.

Common: - Mild local irritation at the infusion site. - Transient increase in blood glucose levels. - Slight electrolyte imbalance, such as mild hypernatremia. - Low‑grade fever or chills during infusion.

Serious: - Severe hypernatremia or hyperglycemia. - Allergic reaction including rash, urticaria, or anaphylaxis. - Fluid overload leading to pulmonary edema. - Electrolyte disturbances causing cardiac arrhythmia.

What precautions apply to Sodium Chloride, Glucose Monohydrate?

When using Glucosio E Sodio Cloruro I Galenica Senese, clinicians should observe several precautions to minimize risk and ensure appropriate therapy.

- Assess baseline serum electrolytes and glucose before initiation. - Adjust infusion rate in patients with renal or cardiac impairment. - Monitor fluid balance and weight to avoid overload. - Use caution in neonates, infants, and the elderly. - Avoid rapid bolus administration unless specifically indicated. - Discontinue if signs of allergic reaction develop. - Store according to manufacturer instructions, protecting from light and temperature extremes.

What does Sodium Chloride, Glucose Monohydrate interact with?

Glucosio E Sodio Cloruro I Galenica Senese may interact with other intravenous agents or medications that affect fluid, electrolyte, or glucose balance.

Avoid: - Concurrent rapid infusion of other hypertonic saline solutions. - Simultaneous administration with drugs that may precipitate in high‑chloride environments (e.g., calcium gluconate).

Use with caution: - Insulin therapy, which can amplify glucose shifts. - Diuretics that alter sodium balance. - Cardiac glycosides, where electrolyte changes may affect drug toxicity. - Blood products, requiring compatible infusion rates.

Frequently asked questions

What clinical conditions warrant the use of Glucosio E Sodio Cloruro I Galenica Senese?+
It is commonly used for dehydration, postoperative fluid loss, hypoglycemia, and as part of parenteral nutrition to provide both electrolytes and carbohydrate calories.
How does Glucosio E Sodio Cloruro I Galenica Senese differ from plain saline solutions?+
In addition to sodium chloride, it contains glucose monohydrate, supplying an energy source while also restoring extracellular fluid volume.
Can Glucosio E Sodio Cloruro I Galenica Senese be administered through a peripheral IV line?+
Yes, it is formulated for peripheral or central intravenous administration, provided the infusion rate is appropriate for the patient’s condition.
What monitoring is recommended during infusion of Glucosio E Sodio Cloruro I Galenica Senese?+
Regular checks of serum electrolytes, blood glucose, fluid balance, and vital signs are advised to detect any imbalance early.
Is Glucosio E Sodio Cloruro I Galenica Senese suitable for pediatric patients?+
It may be used in children, including neonates, but dosing and infusion rates should be adjusted based on age, weight, and clinical status.
What are the storage requirements for this injectable solution?+
The product should be stored at controlled room temperature, protected from light, and used before the expiration date indicated on the vial.
Should Glucosio E Sodio Cloruro I Galenica Senese be mixed with other IV medications?+
Compatibility should be confirmed before mixing; avoid combining with hypertonic saline or drugs that may precipitate in high‑chloride environments.
How does the glucose component affect patients with diabetes?+
The glucose can raise blood sugar levels; diabetic patients require close glucose monitoring and possible insulin adjustment during infusion.
What signs indicate a serious adverse reaction to this IV solution?+
Symptoms such as severe hyperglycemia, hypernatremia, allergic rash, anaphylaxis, pulmonary edema, or cardiac arrhythmia require immediate medical attention.
Is a prescription required to obtain Glucosio E Sodio Cloruro I Galenica Senese?+
Yes, it is classified as a prescription‑only medication and must be ordered by a licensed healthcare professional.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Sodium Chloride, Glucose Monohydrate
Route
Intravenous Use
Manufacturer
Industria Farmaceutica Galenica Senese S.R.L..
Origin
EU

Related products